We are live on
!
Find out more
MC
Martin & Co Portfolio holdings
AUM
$640M
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+4.53%
1 Year Est. Return
+23.57%
3 Year Est. Return
+67.79%
5 Year Est. Return
+76.4%
10 Year Est. Return
+289.06%
AUM
$316M
AUM Growth
+$14.1M
(+4.7%)
Cap. Flow
+$2.68M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
25.51%
Holding
110
New
4
Increased
95
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.48M |
| 2 |
CNSL
Consolidated Communications Holdings, Inc.
CNSL
|
+$661K |
| 3 |
iShares US Oil & Gas Exploration & Production ETF
IEO
|
+$290K |
| 4 |
SPTN
SpartanNash
SPTN
|
+$226K |
| 5 |
Lowe's Companies
LOW
|
+$180K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$2.08M |
| 2 |
ENVE
ENVENTIS CORP COM STK
ENVE
|
+$819K |
| 3 |
MDCI
MEDICAL ACTION INDS INC
MDCI
|
+$557K |
| 4 |
APA Corp
APA
|
+$262K |
| 5 |
SMA
SYMMETRY MEDICAL INC
SMA
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.73% |
| 2 | Technology | 11.52% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 7.72% |
Similar funds
AMCA
SIM
IF
KJWM
SCA
GG
FWM
AHSW
Martin & Co's Q4 2014 Portfolio in Review
As of Q4 2014, Martin & Co held 110 positions worth $316M, up 4.7% from $302M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Martin & Co's Q4 2014 filing shows 4 new, 95 increased, 5 reduced and 3 closed positions. Its largest new stake was Express Scripts Holding Company: 31,805 shares worth $2.69M. The largest sale was Amgen, an estimated $2.08M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 39% a quarter earlier, followed by Technology and Healthcare.
- Martin & Co's largest Q4 2014 buy was Express Scripts Holding Company: 31,805 shares worth $2.69M.
- Martin & Co added most to iShares US Oil & Gas Exploration & Production ETF in Q4 2014, an estimated $290K increase.
- Martin & Co's biggest Q4 2014 reduction was Amgen, cutting an estimated $2.08M.
- Martin & Co fully exited ENVENTIS CORP COM STK in Q4 2014, selling an estimated $819K.
- Martin & Co's ten largest holdings make up 26% of its $316M portfolio in Q4 2014.
- Martin & Co opened 4 new positions and closed 3 in Q4 2014.
- Martin & Co's portfolio value rose 4.7% quarter-over-quarter to $316M.
Based on Martin & Co's 13F filing for Q4 2014, filed 18 Feb 2015.